BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24893346)

  • 1. Consideration of criteria required for assignment of a (skin) sensitiser a substance of very high concern (SVHC) under the REACH regulation.
    Basketter D; Kimber I
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):524-8. PubMed ID: 24893346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Categorisation of protein respiratory allergens: the case of Subtilisin.
    Kimber I; Basketter DA
    Regul Toxicol Pharmacol; 2014 Apr; 68(3):488-92. PubMed ID: 24534002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation.
    Basketter D; Poole A; Kimber I
    Regul Toxicol Pharmacol; 2017 Jun; 86():101-106. PubMed ID: 28274809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the skin sensitising potency of the lower alkyl methacrylate esters.
    Kimber I; Pemberton MA
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):24-36. PubMed ID: 24956587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trade Union Priority List for REACH authorisation.
    Romano D; Santos T; Gadea R
    J Epidemiol Community Health; 2011 Jan; 65(1):8-13. PubMed ID: 20508006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of skin sensitisation potential.
    Roberts DW; Aptula AO
    J Appl Toxicol; 2008 Apr; 28(3):377-87. PubMed ID: 17703504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragrance sensitisers: Is inhalation an allergy risk?
    Basketter D; Kimber I
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):897-902. PubMed ID: 26433121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency.
    Kimber I; Maxwell G; Gilmour N; Dearman RJ; Friedmann PS; Martin SF
    Toxicology; 2012 Jan; 291(1-3):18-24. PubMed ID: 22120538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of contact allergens according to potency: proposals.
    Kimber I; Basketter DA; Butler M; Gamer A; Garrigue JL; Gerberick GF; Newsome C; Steiling W; Vohr HW
    Food Chem Toxicol; 2003 Dec; 41(12):1799-809. PubMed ID: 14563405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the potency of respiratory allergens: uncertainties and challenges.
    Basketter DA; Kimber I
    Regul Toxicol Pharmacol; 2011 Dec; 61(3):365-72. PubMed ID: 22019813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles for identification of High Potency Category Chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be applied.
    Roberts DW; Api AM; Safford RJ; Lalko JF
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):683-93. PubMed ID: 25765509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
    Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
    Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
    Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
    Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk management of skin sensitisers: A commentary.
    Basketter DA
    Regul Toxicol Pharmacol; 2023 May; 140():105384. PubMed ID: 37028500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of chemicals as sensitisers based on new test methods.
    Botham PA
    Toxicol Lett; 1992 Dec; 64-65 Spec No():165-71. PubMed ID: 1471170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A future approach to measuring relative skin sensitising potency: a proposal.
    Jowsey IR; Basketter DA; Westmoreland C; Kimber I
    J Appl Toxicol; 2006; 26(4):341-50. PubMed ID: 16773645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency values from the local lymph node assay: application to classification, labelling and risk assessment.
    Loveless SE; Api AM; Crevel RW; Debruyne E; Gamer A; Jowsey IR; Kern P; Kimber I; Lea L; Lloyd P; Mehmood Z; Steiling W; Veenstra G; Woolhiser M; Hennes C
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):54-66. PubMed ID: 19733604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SVHC in imported articles: REACH authorisation requirement justified under WTO rules.
    Schenten J; Führ M
    Environ Sci Eur; 2016; 28(1):21. PubMed ID: 27752454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro approaches to the identification and characterization of skin sensitizers.
    Basketter D; Maxwell G
    Cutan Ocul Toxicol; 2007; 26(4):359-73. PubMed ID: 18058309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin sensitisation, vehicle effects and the local lymph node assay.
    Basketter DA; Gerberick GF; Kimber I
    Food Chem Toxicol; 2001 Jun; 39(6):621-7. PubMed ID: 11346493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.